Old Web
English
Sign In
Acemap
>
authorDetail
>
David A. Parks
David A. Parks
Idaho National Laboratory
Regimen
Virology
Medicine
Internal medicine
Rilpivirine
3
Papers
41
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Durable Suppression and Low Rate of Virologic Failure 3 Years After Switch to Dolutegravir + Rilpivirine 2-Drug Regimen: 148-Week Results From the SWORD-1 and -2 Randomized Clinical Trials.
2020
Journal of Acquired Immune Deficiency Syndromes
Jean van Wyk
Chloe Orkin
Rafael Rubio
Johannes Bogner
David Baker
Marie-Aude Khuong-Josses
David A. Parks
Konstantinos Angelis
Lesley P Kahl
Jessica E. Matthews
Ruolan Wang
Mark R. Underwood
Brian Wynne
Maria Claudia Nascimento
Kati Vandermeulen
Martin Gartland
Kimberly Y. Smith
Show All
Source
Cite
Save
Citations (8)
319. SWORD 1 and 2: Switch from TDF Containing Regimen to DTG+RPV Maintains Bone Mineral Density and Decreases Bone Turnover Markers Over 148 Weeks
2019
Open Forum Infectious Diseases
Lesley P Kahl
Grace A McComsey
Mónica Coronado Poggio
Sergio H. Lupo
Joss de Wet
David A. Parks
Brian Wynne
Martin Gartland
Kostas Angelis
Alicia Aylott
Michael Cupo
Kati Vandermeulen
Jean van Wyk
K. Smith
Show All
Source
Cite
Save
Citations (0)
Radiation tolerance of piezoelectric bulk single-crystal aluminum nitride
2014
IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control
David A. Parks
Bernhard R. Tittmann
Show All
Source
Cite
Save
Citations (33)
1